department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

when

Latest
Archive

by source

All Sources
Sources Page

by activity

Most Active
Biggest Pipelines
Recently Active

hiring

Companies Hiring Now
Big Pharma Roles
All Companies →

Drugs & Pipeline

intelligence

Drugs
Patent Cliff

research

Publications
Topics

window

Next 90 Days
All (incl. Past)

by type

PDUFAs
Approvals
Earnings
Readouts

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Calendar
Drugs
Companies
News

Hubs

Topics
Jobs
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
cal
search

seltorexant · pharmadog

pharmadog
drugs
seltorexant

drug · small molecule

patient view →

seltorexant

Phase 3updated 2mo ago

by $JNJ JOHNSON & JOHNSON🔗 ChEMBL

Phase 3

community read0 votes

Small molecule drug with a maximum clinical stage of Phase 3 (across all indications), with 6 investigational indications.

indications

indications

Major Depression

targets

Orexin receptor type 2

all catalysts(0)

nothing on the calendar yet

News(0)

no news has mentioned this drug yet

generic

seltorexant

MOA

Orexin receptor 2 antagonist

indication

Insomnia

phase

phase_3

Data sources

ClinicalTrials.gov · OpenTargets

last refreshed 1h ago

Found something off?

🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?

Trials studying seltorexant

phase3A Study of Seltorexant as Adjunctive Therapy to Antidepressants in Adult and Elderly Participants With Major Depressive Disorder With Insomnia Symptoms Who Have Responded Inadequately to Antidepressant and Long-term Safety Extension Treatment With Seltorexantcompletedn=588
phase3Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptomsrecruitingn=752
phase3A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disordernot yet recruitingn=600
phase3A Study of Seltorexant Compared to Quetiapine XR as Adjunctive Therapy to Antidepressants in Adult and Elderly Participants With Major Depressive Disorder With Insomnia Symptoms Who Have Responded Inadequately to Antidepressant Therapycompletedn=757
phase3A Study of Seltorexant as Adjunctive Therapy to Antidepressants in Adult and Elderly Participants With Major Depressive Disorder With Insomnia Symptoms Who Have Responded Inadequately to Antidepressant Therapyterminatedn=212
phase1A Study to Evaluate the Effects of Single-dose Seltorexant on Electrocardiogram Intervals in Healthy Adult Participantscompletedn=52
phase1A Study of Seltorexant (JNJ-42847922) After Single-Dose Administration in Healthy Participantscompletedn=151
phase1A Study of JNJ-42847922 (Seltorexant) in Healthy Participantscompletedn=10

more trials →